Barbara Haley

7.7k citations

56 papers · 2.9k indexed · 2 hit papers · h-index 21

Impact in

Oncology top 1%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Bone health and treatments
Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies

Papers in ⓘ

Oncology 37
- HER2/EGFR in Cancer Research 12
- Cancer Treatment and Pharmacology 7
Pulmonary and Respiratory Medicine 20
- Advanced Breast Cancer Therapies 11

Co-authors: Eugene P. Frenkel (8 shared papers)David Euhus (8 shared papers)Marilyn Leitch (6 shared papers)Dorothee Herlyn (2 shared papers)Larry E. Morrison (2 shared papers)Jianqiang Wang (2 shared papers)Jonathan W. Uhr (2 shared papers)Leon W.M.M. Terstappen (2 shared papers)
Journals: Journal of Clinical Oncology (12 papers)Cancer Research (5 papers)International Journal of Radiation Oncology*Biology*Physics (5 papers)Clinical Breast Cancer (3 papers)Clinical Cancer Research (2 papers)
Partner nations: United States Spain Canada

In The Last Decade

Barbara Haley

54 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Nanoparticles for drug delivery in cancer treatment 2008 · 596 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Urologic Oncology Seminars and Original Investigations
2004 Clinical Cancer Research

Peers

Countries citing papers authored by Barbara Haley

Since Specialization

Citations

This map shows the geographic impact of Barbara Haley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Haley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Haley more than expected).

Fields of papers citing papers by Barbara Haley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Haley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Haley. The network helps show where Barbara Haley may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara Haley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Haley Line = papers co-authored together Barbara Haley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Circulating Tumor Cells in Patients with Breast Cancer Dormancy Clinical Cancer Research ·Songdong Meng, Debasish Tripathy, Eugene P. Frenkel, Sanjay Shete, Elizabeth Z. Naftalis, James F. Huth, Peter D. Beitsch, Marilyn Leitch, Susan Hoover, David Euhus, Barbara Haley, Larry E. Morrison, Timothy P. Fleming, Dorothee Herlyn, Leon W.M.M. Terstappen, Tanja Fehm, Thomas F. Tucker, Nancy Lane, Jianqiang Wang, Jonathan W. Uhr Hit paper breakdown →	2004	778
2	Nanoparticles for drug delivery in cancer treatment Urologic Oncology Seminars and Original Investigations ·Barbara Haley, Eugene P. Frenkel Hit paper breakdown →	2008	596
3	Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results Clinical Breast Cancer ·Adam Brufsky, Linda D. Bosserman, R. Caradonna, Barbara Haley, C. Michael Jones, Halle C. F. Moore, Lixian Jin, Ghulam Warsi, Solveig G. Ericson, Edith A. Perez	2009	166
4	Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102 Journal of Clinical Oncology ·Noah Kornblum, Fengmin Zhao, Judith Manola, Paula Klein, Bhuvaneswari Ramaswamy, Adam Brufsky, Phillip J. Stella, Brian L. Burnette, Melinda L. Telli, Della Makower, P. Cheema, Cristina I. Truica, Antonio C. Wolff, Gamini S. Soori, Barbara Haley, Timothy R. Wassenaar, Lori J. Goldstein, Kathy D. Miller, Joseph A. Sparano	2018	141
5	uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues Proceedings of the National Academy of Sciences ·Songdong Meng, Debu Tripathy, Sanjay Shete, Raheela Ashfaq, Hossein Saboorian, Barbara Haley, Eugene P. Frenkel, David Euhus, Marilyn Leitch, Cynthia R. Osborne, Edward Clifford, Steve Perkins, Peter D. Beitsch, Amanullah Khan, Larry E. Morrison, Dorothee Herlyn, Leon W.M.M. Terstappen, Nancy Lane, Jianqiang Wang, Jonathan W. Uhr	2006	127
6	Assessment of HER-2/neu Status in Breast Cancer American Journal of Clinical Pathology ·Sijian Wang, M. Hossein Saboorian, Eugene P. Frenkel, Barbara Haley, Momin T. Siddiqui, S. Tunc Gokaslan, Frank H. Wians, Linda S. Hynan, Raheela Ashfaq	2001	116
7	Aneusomy 17 in Breast Cancer: Its Role in HER-2/neu Protein Expression and Implication for Clinical Assessment of HER-2/neu Status Modern Pathology ·Sijian Wang, M. Hossein Saboorian, Eugene P. Frenkel, Barbara Haley, Momin T. Siddiqui, S. Tunc Gokaslan, Linda S. Hynan, Raheela Ashfaq	2002	111
8	Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone JAMA Oncology ·Gabriel N. Hortobágyi, Catherine Van Poznak, W G Harker, William J. Gradishar, Helen K. Chew, Shaker R. Dakhil, Barbara Haley, Nicholas Sauter, Ramon Mohanlal, Ming Zheng, Allan Lipton	2017	104
9	Decreased Androgen Receptor Expression Is Associated With Distant Metastases in Patients With Androgen Receptor–Expressing Triple-Negative Breast Carcinoma American Journal of Clinical Pathology ·Lisa Sutton, Dengfeng Cao, Venetia Sarode, Kyle Molberg, Kwame Torgbe, Barbara Haley, Yan Peng	2012	84
10	SOPHIA primary analysis: A phase 3 (P3) study of margetuximab (M) + chemotherapy (C) versus trastuzumab (T) + C in patients (pts) with HER2+ metastatic (met) breast cancer (MBC) after prior anti-HER2 therapies (Tx). Journal of Clinical Oncology ·Hope S. Rugo, Seock‐Ah Im, Gail Lynn Shaw Wright, Santiago Escrivá-de-Romaní, Michelino De Laurentiis, Javier Cortés, Shakeela Bahadur, Barbara Haley, Raul H. Oyola, David Riseberg, Antonino Musolino, Fátima Cardoso, Giuseppe Curigliano, Peter A. Kaufman, Mark D. Pegram, Sutton Edlich, Sam Pyo Hong, Edwin P. Rock, William J. Gradishar	2019	62
11	Assessing problem feeding behaviors in mid-stage Alzheimer's disease Geriatric Nursing ·Tana Durnbaugh, Barbara Haley, Sharon Roberts	1996	50
12	Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation International Journal of Radiation OncologyBiologyPhysics ·Asal Rahimi, K. Thomas, Ann Spangler, Roshni Rao, Marilyn Leitch, Rachel Wooldridge, Aeisha Rivers, Stephen Seiler, Kevin Albuquerque, Stella Stevenson, Sally Goudreau, Dan Garwood, Barbara Haley, David Euhus, J.H. Heinzerling, Chuxiong Ding, Ang Gao, Chul Ahn, Robert Timmerman	2017	49
13	Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients Clinical Cancer Research ·Masato Kobayashi, Jin-Sung Chung, Muhammad Shaalan Beg, Yull Arriaga, Udit Verma, Kevin D. Courtney, John C. Mansour, Barbara Haley, Saad A. Khan, Yutaka Horiuchi, Vijay Ramani, David Harker, Purva Gopal, Farshid Araghizadeh, Ponciano D. Cruz, Kiyoshi Ariizumi	2018	46
14	Bootcamp during Neoadjuvant Chemotherapy for Breast Cancer: A Randomized Pilot Trial Breast Cancer Basic and Clinical Research ·Roshni Rao, Veronica Cruz, Yan Peng, Amy Harker-Murray, Barbara Haley, Shihua Zhao, Xian-Jin Xie, David Euhus	2012	39
15	Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients Breast Cancer Research and Treatment ·Jean Shiao, K. Thomas, Asal Rahimi, Roshni Rao, Jingsheng Yan, Xian‐Jin Xie, Marcelo Dasilva, Ann Spangler, M. Leitch, Rachel Wooldridge, Aeisha Rivers, Deborah Farr, Barbara Haley, D. W. Nathan Kim	2016	31
16	Phase I/II study of H3B-6545, a novel selective estrogen receptor covalent antagonist (SERCA), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer. Journal of Clinical Oncology ·Erika Hamilton, Judy S. Wang, Timothy Pluard, Stephen Johnston, Aki Morikawa, Elizabeth Claire Dees, Robert H. Jones, Barbara Haley, Anne Armstrong, Adam L. Cohen, Pamela N. Münster, Gail Lynn Shaw Wright, Fadi Kayali, Manav Korpal, Jianjun Xiao, Jenny Long, Benoit Destenaves, Lei Gao, Antonio Gualberto, Dejan Juric	2021	31
17	Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases Clinical Breast Cancer ·Rati Chkheidze, Mary Ann Sanders, Barbara Haley, A. Marilyn Leitch, Sunati Sahoo	2017	25
18	Abstract S1-02: PrECOG 0102: A randomized, double-blind, phase II trial of fulvestrant plus everolimus or placebo in post-menopausal women with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer (MBC) resistant to aromatase inhibitor (AI) therapy Cancer Research ·NS Kornblum, Judith Manola, Paula Klein, B Ramaswamy, Adam Brufsky, PJ Stella, Barry Burnette, Melinda L. Telli, DF Makower, Joseph W. Leach, CI Truica, Antonio C. Wolff, GS Soori, Barbara Haley, Arun Nagarajan, TR Wassenaar, Lori J. Goldstein, KD Miller, JA Sparano	2017	24
19	PrECOG 0105: Final efficacy results from a phase II study of gemcitabine (G) and carboplatin (C) plus iniparib (BSI-201) as neoadjuvant therapy for triple-negative (TN) and BRCA1/2 mutation-associated breast cancer. Journal of Clinical Oncology ·Melinda L. Telli, Kristin C. Jensen, Allison W. Kurian, Shaveta Vinayak, Jafi A. Lipson, Elizabeth Schackmann, Irene Wapnir, Robert W. Carlson, Joseph A. Sparano, Bobbie Head, Lori J. Goldstein, Barbara Haley, Shaker R. Dakhil, Judith Manola, James M. Ford	2013	24
20	Adaptively randomized trial of neoadjuvant chemotherapy with or without the Akt inhibitor MK-2206: Graduation results from the I-SPY 2 Trial. Journal of Clinical Oncology ·Debu Tripathy, A. Jo Chien, Nola M. Hylton, Meredith Buxton, Cheryl Ann Ewing, Anne M. Wallace, Andres Forero, Henry G. Kaplan, Rita Nanda, Kathy S. Albain, Stacy L. Moulder, Barbara Haley, Angela DeMichele, W. Fraser Symmans, Laura van ‘t Veer, Melissa Paoloni, Laura J. Esserman, Donald A. Berry, Douglas Yee	2015	23

About Barbara Haley

Barbara Haley is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 56 papers that have together received 2.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (12 papers), Advanced Breast Cancer Therapies (11 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Genomics and Diagnostics (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), BRCA gene mutations in cancer (4 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (912 citations), Biomaterials (404 citations), Pulmonary and Respiratory Medicine (629 citations) and Radiology, Nuclear Medicine and Imaging (421 citations). Barbara Haley has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Eugene P. Frenkel, David Euhus, Marilyn Leitch, Dorothee Herlyn, Larry E. Morrison, Jianqiang Wang, Jonathan W. Uhr, Leon W.M.M. Terstappen, Songdong Meng and Nancy Lane. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, International Journal of Radiation Oncology*Biology*Physics, Clinical Breast Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact